Dianthus Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Dianthus Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Dianthus Therapeutics Inc
Rating: 1.71558325
Author: Trendlyne DVM scores

about

Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next...

23.57 -1.24 (-5.00%)

26.96% Fall from 52W High

345.9K

XNAS Volume

XNAS 29 Aug, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

10.3 / 100

Technically Neutral

58.3 / 100

1Yr Price target upside is 123%

11 analysts

Dianthus Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Dianthus Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next...

26.96% Fall from 52W High

SWOT Analysis

Dianthus Therapeutics Inc Live Price Chart